MTOR and acute lymphoblastic leukemia: mTOR inhibition either alone or in association with conventional ALL therapies or with targeted drugs for different cellular cascades is able to block distinct mechanisms of cell survival in ALL, providing a strong rationale for the investigation of mTOR inhibition particularly in the setting of resistance to chemotherapeutic drugs.